Related Experiment Video
Updated: Aug 14, 2026

Orthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma Model
Published on: October 2, 2015
The incidence of pleural mesothelioma in chrysotile asbestos textile workers
Abstract:
Analysis of the incidence of pleural mesothelioma in asbestos textile workers in relation to age, time since first exposure, intensity of exposure and period of observation indicates that age per se is largely irrelevant; that is, the incidence 30 years after first exposure appears to be much the same irrespective of age at first exposure. This has been shown to be true in animal experiments and has been suggested on theoretical grounds for certain human cancers; it explains the evolution of lung cancer rates in relation to changing smoking habits but has not been demonstrated directly by human data. These results also suggest that mesothelioma incidence may not have been much underestimated in the past, which would imply that the recent marked increase in recorded rates is largely real and not merely a diagnostic artefact. The risk does not appear to have been much higher among men who were initially very heavily exposed. One possible explanation of this surprising observation is that chrysotile is eliminated, or ceases to be biologically active, more quickly than other types of asbestos.
Related Concept Videos
Pleura of the Lungs
Pleural Disorders: Types and Brief Description
Pleural Effusion I: Introduction
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's criteria,...
Pleural Effusion II: Symptoms and Management
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
Pneumothorax-II
Clinical Manifestations:
Chronic Obstructive Pulmonary Disease II: Emphysema

